1
NATIONAL PHARMACEUTICAL UNIVERSITY Department of Pharmacology
Medicines suppressing the cental nervous system (CNS depressant) 2
Neuroleptics (ANTIPSYCHOTIC MEDICINES) Neuroleptics are psychotropic medicines that are able to reveal the inhibitory action on the CNS (without consciousness disturbing) eliminate hallucinations, delirium and stop the psychomotor excitation (motor and speech). 7 Classification of neuroleptics
Derivatives of
phenotiazine butyrophenone Thioxanthene *, dibenzodiazepine #, benzamide &, benzisoxazole $
Clozapine # Chlorpromazine Droperidol Chlorprothixene * Levomepromazine Haloperidol Sulpyrid & Perphenazine Risperidone $ hydrochloride 3
Pharmacological action Antipsychotic effect (elimination of delusions, aggression) is associated with blockade of dopaminergic D2 receptor reticular formation (removed activating influence on the cortex of the brain), nuclei, midbrain, limbic system, hypothalamus. With the same linked primary and side effects - extrapyramidal disorder, a syndrome similar to Parkinson's disease. Potential action is caused by blockade a-AR and reticular formation.
Antiemetic effect is related to the blockade of dopaminergic (D2) and serotonin receptors "trigger zone“ of medula oblongata and termination of the signals in the emetic center. 4
The Hypothermic effect is the result of adreno- and serotonin receptors blockade and, therefore, decrease of the activity of the hypothalamic thermoregulation centres (decrease of the heat production and increase of the heat emission). The Antihistamine effect implemented by the blockade of H1- histamine receptors. The Hypotensive effect - the result of blockade of AR and a- dofaminoretseptors in the hypothalamus and peripheral vessels. The Neuroleptic (weakness, drowsiness, paralysis of will", motor inhibition) action - blockade of central and a-AR reticular formation, limbic system, hypothalamus. 5 Effects and related indications
Pharmacodynamics (effects) → Indications Antipsychotic Psychosis (schizophrenia etc.)
Potentiating Neuroleptanalgesia, potentiation (for medicines that suppress CNS) of narcosis Anti-emetic Uncontrolled vomiting of the central genesis (in pregnant women with anti-tumor therapy) Hypothermic Controlled hypothermia during narcosis Antihistaminic Severe neurodermitis
Hypotensive Severe forms of arterial hypertension with psychomotor excitation (chlorpromazine only) 6 Side effects of typical neuroleptics and related contraindications Side effects → Contraindications
Neuroleptic syndrome, drug- Depression, parkinsonism induced parkinsonism, dyspepsia
Derivatives of phenotiazine, butyrophenone, thioxanthene called "typical" neuroleptics, as they lead to the development of medicinal parkinsonism ( D2 receptor in the black substance and striped body region)-extrapyramidal disorders. Risperidone, clozapine are atypical neuroleptics Atypical Antipsychotics, or Second Generation Antipsychotic Drugs
These new medications were approved for use in the 1990s. Clozapine, asenapine, olanzapine, quetiapine, paliperidone, risperidone, sertindole, ziprasidone, zotepine, and aripiprazole are atypical antipsychotic drugs. With the discovery of clozapine in 1959, it became evident that this drug was less likely to produce extrapyramidal effects (physical symptoms such as tremors, paranoia, anxiety, dystonia, etc. as a result of improper doses or adverse reactions to this class of drug) in humans at clinically effective doses than some other types of antipsychotics. Clozapine was categorized as the first atypical antipsychotic drug. This category of drugs has also been of great value in studying the pathophysiology of schizophrenia and other psychoses. 8 The pharmacological “face” of neuroleptics Antipsychotic effect : Haloperidol Droperidol Closapine Chlorprothixene = Chlorpromazine =Perphenazine hydrochloride=Sulpyrid Levomepromazine
Potentiating effect: Haloperidol Droperidol Levomepromazine Chlorpromazine. Anti-emetic effect : Haloperidol Perphenazine hydrochloride Droperidol Sulpyrid Chlorpromazine Neuroleptic effect : Derivatives of phenothiazine = butyrophenone thioxanthene Closapine Sulpyrid. 9
TRANQUILIZERS (ANXIOLYTICS, ATARACTICS, ANTIPHOBIC MEDICINES)
Tranquilizers (in Latin tranquillare – „to make calm”) are medicines that remove selectively fair, anxiety, emotional tension increased restlessness and are used mainly in neuroses and the related states. 14
Classification of tranquilizers
Derivatives of benzodiazepines Derivatives of diphenylmetanum and other chemical groups
Diazepan Alprazolam Hydroxysine* Phenazepam Lorazepam Meprobamat Chlordiazepoxide Gidazepam
Medazepam, Gidazepam, Trimetosine are “day time” tranquilizers as they cause less inhibition of CNS than other medicines, therefore,they can be used in day time. 10
The mechanism of action They decrease the excitability of subcortical regions of the brain (the limbic system, thalamus, the reticular formation, the hypothalamus), that are responsible for emotional reactions, inhibit the interaction between these structures and the brain cortex.
Benzodiazepines stimulate mainly benzodiazepine receptors and that leads to activation of GABA-receptors and intensification of the inhibitory functions of GABA . 11
Benzodiazepines
GABA Extracellular compartment
Membrane Ion of neuron channel
Cytoplasm
The mechanism of Benzodiazepines action 12 Effects and related indications
Pharmacodynamics (effects) → Indications
Аnxiolytic Neuroses
Stress-protective Stress-reaction
Hypnotic Insomnia (especially caused by negative emotions)
Sedative Neurogenic diseases
Anticonvulsant Convulsions (epilepsy)
Potentiating Premedication 13
Side effects and related contraindications
Side effects → Contraindications
Drowsiness, weakness, Activities that require rapid disorders of attention and psychomotor reactions. Long- locomotion, tolerance, addiction term courses of treatment. Increase of doses 15
The pharmacological «face» of tranquilizers Medicines Tranquili- Addiction/ Side Other effects zing effect tolerance effects
Phenazepam ++++ +/+ + Anticonvulsant, hypnotic, sedative, spasmolytic (diazepam) Diazepam +++ +/+ ++ Chlordiaze- ++ +/+ + poxide Lorazepam ++ - + Accumulation, anticonvulsant, hypnotic
Alprazolam + - + Anticonvulsant, antidepressant
Gidazepam + - Anticonvulsant, potentiating, stimulating
Hydroxysi- - + Analgesic, myorelaxant, antiemic ne
Meproba- + ++/+ ++ Anticonvulsant mat 16
Sedative Medicines
Sedative medicines (in Latin sedatio is calming) are medicines that cause a moderate sedative effect as a result of decrease of CNS excitability and its reactivity of different stimuli
The mechanism of action They increase of the inhibitory processes in the CNS and decrease of the excitability of the reticular formation and the brain cortex. 19
Classification of medicines
Plant Bromide compounds * origin and Combined **
Persenum** Sodium bromide* Valerian extract Corvalol** (Valocordin) Novo-passit** Valocormide** 17 Effects and related indications
Pharmacodynamics (effects) → Indications Sedative Neuroses, increased irritability, neurogenic disease, insomnia Stress-protective Stress-reaction
Potentiating Intensification of effects of CNS depressants, the early stage of hypertension Side effects → Contraindications Decrease of the mental and Activities that require rapid physical activity, feeling of psychomotor reactions fatigue, drowsiness 18
The features of sedative medicines is the lack of significant side effects because they are widely used in outpatient practice and in elderly patients. At long use drugs generates bromine "bromizm": general retardation, drowsiness, weakening of memory, apathy, decreased potency, tearing, cough, running nose, skin rash. Treatment: immediately stop taking the drug, the introduction of large numbers of sodium chloride (20 g per day) and need to drink a lot. 20
Pharmacological «face» of sedative drugs Preparations Effects Composition/other effects Sedative Spasmolytic
Sodium +++ Anticonvulsant bromide Urticae ++ Canine Tincture
Valerian + + Spasmolytic extract Persen + + Mint, Melissa Corvalol ++ + Phenobarbital, mint oil
Valocordin + + Sodium bromide, Convallaria, Belladonna, Menthol Novo-passit ++ + Guaphenesine, extracts of Crataegus, Humulus, Hypericum, Milissa, Passiflora, Sambucus 21
Hypnotic medicines Disorders of sleep (insomnia, hyposomnia) are one of the states that are common and occur independently (primary insomnia), and at the different somatic and psychiatric pathologies (the secondary insomnia). If the sleep disorder is repeated more than 4 times a week, which requires pharmacological correction as insomnia (violation of physiological rhythms in the CNS) leads to overexcited, fatigue, exhaustion of the brain and, consequently, to different forms of pathology of neurogenic origin. Hypnotics are products that tend to restore the process of falling asleep, sleep duration and depth of their violation. 22
The mechanism of action of sedative medicines Inhibit some brain structures (mainly cerebral cortex). Weaken the activating reticular formation of the discharges in the cerebral cortex. In the mechanism of action of benzodiazepine and barbituric acid an important part plays their relationship with benzodiazepine receptors and barbiturate-benzodiazepine-GABA receptor complex, leading to strengthening of the natural inhibitory neurotransmitter GABA (gamma amino butyric acid) 23 Hypnotics
Pharmacodynamics (effects) → Indications Hypnotic Disorder of sleep Potentiating Intensification of the effects of CNS depressants Sedative(low doses) Mild neuroses, neurotic syndrome
Side effects → Contraindications Apathy, drowsiness, weakness Activities that require the rapid psychomotor reactions Most sleeping drugs causes the violation of the structure sleep syndrome "aftereffect", "return", “withdrawal", physical and psychological dependence, addiction, cummulation (especially barbiturates). Closest to the ideal of sleeping drugs - zopiklon and zolpidem. 24
Classification of medicines
Derivatives of Derivatives of Combined medicines benzodiazepine, cyclopyrrolone, barbituric acid imidazopyridine,* methylbutamide** Nitrozepam Zopiclone Reladorm Phenobarbital Zolpidem* (cyclobarbital + Cyclobarbital* Bromisoval** diazepam) 25
The pharmacological «face» of hypnotic medicines Phenobarbital reladorm bromisoval zolpidem = zopiclon nitrazepam
Medicines Sleep Accu- Addiction Effective in disorder of Withdra- Disorder After duration mulati wal of the action -on Falling Sleep sleep asleep duration phases Phenobarbital 8-10 +++ +++ + + +++ + +++ Cyclobarbital 5-6 ++ +++ + +++ + ++ Nitrazepam 6-8 + ++ + + ++ + ++ Zopiderm 6-8 - + + + -
Zopiclone 6 - + + -
Bromisoval 6 ++ - + - ++
Reladorm 6 ++ +++ + + +++ ++ 27
Anticonvulsants Anticonvulsant medicines decrease or stop convulsions in pathological states of the organism
Mechanism of action Inhibition the pathological activity of neurons in epileptic foci of motor cortex areas and subcortical structures by reducing the utilization of O2, energetic and exciting action of amino acids (glutaminum and aspartamum), blocking Ca- and Na-channels in the epileptic foci, stimulation of GABA- ergic inhibitory mechanisms 30
Classification
Benzodiazepines Valproates Barbiturates
Diazepam Valproic acid Benzobarbital Clonazepam Phenobarbital
Succinimides Iminostilbens Others
Ethosuccimide Carbamazepine Tolperizone 28 Effects and related indications
Pharmacodynamics (effects) → Indications
Anticonvulsant effect Convulsions of different origin (epilepsy, craniocerebral traumas, tumours of the CNS, meningitis)
Side effects → Contraindications
CNS inhibition, mental confusion, Activities that require attention, drowsiness, depression, tolerance depression 29
The principles of correct usage of anticonvulsants: - Individually assemble the necessary combination of drugs; - Increase the dose gradually; - Evaluate the effectiveness of drugs in a few weeks of treatment (number of convulsions should decrease by 50%); - If necessary to make the gradual replacement of one drug, reducing its dose, the second (in increasing doses); - Conduct continuous therapy (discontinuation of the drug allowed after 4-5 years in the absence of pathological changes in electroencephalogram). 34
Antiparkinsonian medicines Pharmacodynamics (effects) → Indications Antiparksionian effect Parkinsons desease, Parkinson syndrome
Side effects → Contraindications Antiholynergic tachycardia glaucoma, constipation
Dophaminenergic psychosis
Antiglutamatergic Epilepsy, hypotension
All medications must be taken with brief intervals (1-2 days / week) for the prevention of tolerance (habituation). 31
The pharmacological «face» of anticonvulsants Medicines Convulsive attacks: Epyleptic status SE Other effects g\s Benzobarbital + - + Sedative, hypnotic - Phenobarbital + + ++ - Diazepam + +++ Sedative, hypnotic, - tranquilizing Clonazepam + + ++ + Carbamazepine + - +++ Antidepressant, - normothymic, analgesic Valproic acid + - + Anxiolytic + Ethosuccimide - - + Tranquilizing, analgesic + Tolperizone - - + Sedative, hypnotic + 33 Drugs for parkinsonism treatment Drugs used to treat Parkinson disease and syndrome of parkinsonism, including medicinal parkinsonism. Mechanism of action At these diseases in the CNS is disturbed balance of neurotransmitters: the quantity of dopamine and acetylcholine content is increased. These means restoring the balance between dopaminergic and cholinergic brain systems. The mechanism of action of drugs are divided into: I. Anticholinergic - blocking the central (reducing the influence of acetylcholine in the CNS) and peripheral M-cholinoreceptors. II. Dopaminergic - restore the dopamine deficiency in the CNS. III. Antyglutamatergic - reduce the exciting action of glutamate neurons in the CNS, which develop on the background of dopaminergic system failure. 35
Classification of medicines
Anticholinergic Dophaminer- Antiglutamatergic (cholinolytic) gic ones ones
Trihexiphenydil Levodopa Amantadine Levodopa + carbidopa (Nacom) Bromocriptine Selegiline 32 Mechanism of action CNS Dopaminergic ending
Levodopa Levodopa
DOPA decarboxylase
Dopamine
Selegiline
Dopamine release Amantadine Dopamine reuptake Bromocriptine
Amantadine
Postsinaptic D2-receptors 36
The pharmacological «face» of antiparkinsonian medicines
Medicines Antiparkinsonian Side Other effects effect effects
Levodopa +++ + The maximum effect in a month.Little impact on the autonomic and mental disorders, a characteristic (gold standard phenomenon of "inclusion and exclusion" therapy)
Nacom + +, Combination: levodopa, carbidopa. The effect is rapid, (briefly) tolerance less toxic Selegiline ++ + Antidepressant.The need to combine with levodopa or nakomom Trihexilphe- + ++ Cholinolytic nydil Amantadine + +, Cholinolytic, antiviral tolerance Thank you!